SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-24-142295
Filing Date
2024-05-20
Accepted
2024-05-20 08:43:27
Documents
1
Effectiveness Date
2024-05-20

Document Format Files

Seq Description Document Type Size
1 S-8 POS d821783ds8pos.htm S-8 POS 38853
  Complete submission text file 0001193125-24-142295.txt   40104
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-205220 | Film No.: 24962543
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)